BMS-512148
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BMS-512148, covering 2016-10-27 to 2017-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes [Phase 2, Phase 3]